Daiichi Sankyo, Inc.

Aug 12, 2019

Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions

Jan 29, 2019

Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to "Get Iron Informed"

Oct 23, 2018

Daiichi Sankyo, Inc. Publishes Second Edition of Pain Trends Report

Jun 06, 2018

Daiichi Sankyo's U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In

Mar 27, 2018

Daiichi Sankyo, Inc. and the Crohn's & Colitis Foundation Launch Get Iron Informed

Feb 28, 2018

Daiichi Sankyo, Inc. Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pipeline

Dec 12, 2017

Once-Daily, Oral SAVAYSA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study

Sep 06, 2017

Sanford Burnham Prebys and Daiichi Sankyo Announce Enrollment of First Subject in a Phase 1 Clinical Trial of DS-1211 in Healthy Volunteers

May 30, 2017

Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC Announce Plans for Commercialization of RoxyBond(TM) (oxycodone hydrochloride) Tablets CII in the U.S.